Alerts will be sent to your verified email
Verify EmailLINKPH
Link Pharma Chem
|
Emmessar Biotech&Nut
|
Norris Medicines
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
4.87 % | 13.7 % | 47.03 % |
5yr average Equity Multiplier
|
1.96 | 1.24 | -2.46 |
5yr Average Asset Turnover Ratio
|
1.37 | 0.36 | 0.6 |
5yr Avg Net Profit Margin
|
1.5 % | 71.53 % | -30.66 % |
Price to Book
|
1.26 | 1.82 | 0.0 |
P/E
|
0.0 | 45.41 | 0.0 |
5yr Avg Cash Conversion Cycle
|
74.76 Days | 68.18 Days | 97.28 Days |
Inventory Days
|
54.27 Days | 62.21 Days | 165.43 Days |
Days Receivable
|
53.6 Days | 10.88 Days | 69.98 Days |
Days Payable
|
92.46 Days | 199.95 Days | 260.51 Days |
5yr Average Interest Coverage Ratio
|
3.51 | 815.2 | -1.37 |
5yr Avg ROCE
|
8.64 % | 19.97 % | -19.87 % |
5yr Avg Operating Profit Margin
|
5.7 % | -101.39 % | -6.94 % |
5 yr average Debt to Equity
|
0.46 | 0.0 | -3.0 |
5yr CAGR Net Profit
|
n/a | 0.0 | -15.97 % |
5yr Average Return on Assets
|
2.49 % | 10.86 % | -18.92 % |
Shareholdings
|
|||
Promoter Holding
|
51.49 % | 59.53 % | 34.0 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 1.34 % | -0.04 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Link Pharma Chem
|
Emmessar Biotech&Nut
|
Norris Medicines
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|